Clinical Trials
3 trialsNCT00942422 2015-03-27
Green Tea Extract in Treating Patients With Monoclonal Gammopathy of Undetermined Significance and/or Smoldering Multiple Myeloma
Barbara Ann Karmanos Cancer Institute
Phase 2 Terminated
NCT00588822 2014-05-06
Rituximab in Treating Patients With Peripheral Neuropathy Caused by Monoclonal Gammopathy of Undetermined Significance
Mayo Clinic
Phase 2 Terminated
NCT00899353 2013-12-12
Prevention of Disease Progression in Early Stage Indolent B Cell Malignancies. (SMM)
Marshall University
Phase 2 Terminated